Nausea, headache, fatigue...all cleared up within a week or 2 each time my dose was increased
Most of these follow-ups will be done via the websites chat feature
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces significant weight loss by regulating hunger and metabolism, but some patients report increased hair shedding within weeks of starting treatment
Lancet Diabetes Endocrinol 10(9):634644
Patients experience significant weight loss, even people who have been unable to effectively lose weight in the past
Without GPX4 activator, the downstream metabolites of the 5-LOX, 12-LOX, and 15-LOX pathways were markedly elevated after A23187 stimulation ( Figure 4 ), compared to the normal state ( Supplementary Figure S2 )